Hassenfeld Children's Hospital at NYU Langone Performs Its First Pediatric Heart Transplant
Retrieved on:
Wednesday, September 22, 2021
Heart failure, NYU Langone Health, Dizziness, Society of Thoracic Surgeons, NYU, Heart transplantation, Cardiology, Exercise, Friends, Annals of Pediatric Cardiology, Diagnosis, Hypertrophic cardiomyopathy, Survival rate, Gabriel Andral, Palpitations, Hospital, Patient, Coffee, American Heart Association, Adult, Hassenfeld Children's Hospital, Cardiomyopathy, Surgeon, Division, Transplant, HCM, Arrhythmia, Program, Family, Maz, Disease, Muscle tissue, PAT, Quality of life, SAT, Department, Dentistry, Medical device
NEW YORK, Sept. 22, 2021 /PRNewswire/ -- In a historic first-ever milestone for Hassenfeld Children's Hospital at NYU Langone, a team of pediatric cardiac surgeons successfully replaced the heart of Maz Zisan, an 18-year-old boy from Brooklyn Heights with end-stage heart failure on August 28, 2021.
Key Points:
- "Heart transplantation was the only lifesaving option for Maz to have an improved second chance at life," says Rakesh Singh, MD, medical director of the Pediatric Heart Failure and Transplant Program, pediatric cardiologist and associate professor in the Department of Pediatrics at Hassenfeld Children's Hospital at NYU Langone.
- "The successful completion of our first transplant is a testament to the teamwork within Hassenfeld Children's Hospital at NYU Langone."
- "He is healthy and home thanks to the excellent care he received at every level especially within the Pediatric Heart Failure and Transplant Program here at NYU Langone.
- In September 2020, the Pediatric Heart Failure and Transplant Program, part of the Pediatric Congenital Heart Program at Hassenfeld Children's Hospital, was established.